This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
3D Medicines Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
3D Medicines has a total shareholder equity of CN¥772.9M and total debt of CN¥229.7M, which brings its debt-to-equity ratio to 29.7%. Its total assets and total liabilities are CN¥1.3B and CN¥490.7M respectively.
Belangrijke informatie
29.7%
Verhouding schuld/eigen vermogen
CN¥229.75m
Schuld
| Rente dekkingsratio | n/a |
| Contant | CN¥898.58m |
| Aandelen | CN¥772.87m |
| Totaal verplichtingen | CN¥490.67m |
| Totaal activa | CN¥1.26b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 1244's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥401.9M).
Langlopende schulden: 1244's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥88.8M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 1244 has more cash than its total debt.
Schuld verminderen: Insufficient data to determine if 1244's debt to equity ratio has reduced over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: 1244 has sufficient cash runway for more than 3 years based on its current free cash flow.
Voorspelling contante baan: 1244 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 8.7% each year